Mga Batayang Estadistika
| CIK | 700998 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to CompuMed, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| March 25, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-14210 CompuMed, Inc. (Exact name of registrant as specified in its char |
|
| March 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2011 COMPUMED, INC. |
|
| March 22, 2011 |
Exhibit 99a CompuMed, Inc. Elects To Deregister As SEC Reporting Company to Reduce Operating Costs Company Shares Continue To Trade on Pink Sheets Los Angeles —March 21, 2011-CompuMed, Inc. (OTCQB:CMPD) (http://www.compumed.net) announced today that the Company intends to voluntarily file a Form 15 with the Securities and Exchange Commission (SEC) on or about March 25, 2011, to deregister its comm |
|
| March 22, 2011 |
Exbibit 99b CompuMed, Inc. Offers the INTEL® HEALTH GUIDE as Part of Its Integrated Telecardiology Services Company Offers INTEL® HEALTH GUIDE Pursuant to Agreement with Intel-GE Care Innovations™, LLC Los Angeles – March 21, 2011 – CompuMed, Inc. (OTCQB: CMPD) (http://www.compumed.net), a telemedicine and medical informatics company providing telecardiology services and products for the clinical |
|
| February 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to COMPUMED, INC. (Exact name of reg |
|
| February 11, 2011 |
CUSIP No. 204914402 Exhibit 99.1 JOINT FILING AGREEMENT This JOINT FILING AGREEMENT is entered into as of February 4, 2011, by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of common stock, par value $0.01 per share, of CompuMed, Inc., a Delaware corporation, is, and any amendment thereafter signed by each of the unders |
|
| February 11, 2011 |
Schedule 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* CompuMed, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 204914402 (CUSIP Number) Paula L. Skidmore c/o Nadel and Gussman, LLC 15 East 5th Street, Suite 3200 Tulsa, Oklahoma 74103 (918) 583-3333 (Name, A |
|
| January 21, 2011 |
EXHIBIT 10.19 Promissory Note $300,000.00 Tulsa,Oklahoma January 14, 2010 This Promissory Note (the "Note") is made and executed as of the date referred to above, by and between Boston Avenue Capital LLC, an Oklahoma Limited Liability Company (the "Lender"), and CompuMed, Inc., a Delaware corporation ("Borrower"). By this Note, the Borrower promises and agrees to pay to the order of Lender, at 15 |
|
| January 21, 2011 |
SECOND AMENDED REVOLVING LINE OF CREDIT AGREEMENT EXHIBIT 10.18 SECOND AMENDED REVOLVING LINE OF CREDIT AGREEMENT This Second Amended Revolving Line of Credit Agreement (the "Agreement") is made and entered into in this 14th day of January, 2011 (the “Effective Date”), by and between Boston Avenue Capital LLC, an Oklahoma limited liability company ("Lender"), and CompuMed, Inc., a Delaware corporation ("Borrower"). WHEREAS, Lender and Borrower en |
|
| January 21, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2011 COMPUMED, INC. |
|
| December 29, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ——————— COMPUMED, INC. (Exact name of re |
|
| August 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to COMPUMED, INC. (Exact name of registr |
|
| May 17, 2010 |
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 EXHIBIT 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Maurizio Vecchione, certify that: 1. I have reviewed this quarterly report of CompuMed, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such stat |
|
| May 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to COMPUMED, INC. (Exact name of regist |
|
| April 20, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 8-K ——————— CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 16, 2010 ——————— Compumed, Inc. |
|
| April 20, 2010 |
Exhibit 99.1 |
|
| February 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to COMPUMED, INC. (Exact name of reg |
|
| February 3, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3 )* CompuMed, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 204914402 (CUSIP Number) Paula L. Skidmore c/o Nadel and Gussman, LLC 15 East 5th Street, Suite 3200 Tulsa, Oklahoma 74103 (918) 538-3333 (Name, Address and Tel |
|
| February 3, 2010 |
CUSIP No. 204914402 JOINT FILING AGREEMENT Exhibit 99.1 CUSIP No. 204914402 JOINT FILING AGREEMENT This JOINT FILING AGREEMENT is entered into as of January 22, 2010, by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of common stock, par value $0.01 per share, of CompuMed, Inc., a Delaware corporation, is, and any amendment thereafter signed by each of the unders |
|
| December 29, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— X ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2009 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ——————— COMPUMED, INC. (Exact name of regi |
|
| November 25, 2009 |
EXHIBIT 99.1 November 24, 2009 Re: Financial advisor for CompuMed, Inc. Dear Mr. Crockett: This letter sets forth the terms and conditions on which CompuMed, Inc. (the "Company") has engaged Mark Crockett (the ?Advisor?) for a period of 9 months from the date of this letter (the ?Term?) to provide certain investment banking and financial advisory services in connection with a possible Transaction |
|
| November 25, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 8-K ——————— CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 24, 2009 ——————— Compumed, Inc. |
|
| August 14, 2009 |
United States Securities and Exchange Commission Edgar Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 21, 2009 |
CompuMed 10KSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-KSB/A (Amendment No. 2) ——————— ü ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: SEPTEMBER 30, 2008 Or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ————— |
|
| June 24, 2009 |
Issue No.6 ***Special Investor Q & A #3*** June 2009 Exhibit 99.1 Issue No.6 ***Special Investor Q & A #3*** June 2009 Quick Links Stock Quote Telecardiology Services Skeletal Health Press Room Investor Relations Greetings! This is the third newsletter in our special three-part series focused on answering specific shareholder questions. While the first two dealt with our tele-cardiology and skeletal health businesses (respectively, this issue is foc |
|
| June 24, 2009 |
United States Securities & Exchange Commission EDGAR Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 11, 2009 |
United States Securities & Exchange Commission EDGAR Filing 5777 W. Century Blvd., Suite 360 Los Angeles, CA 90045 Tel: (310) 258-5000 Fax: (310) 645-5880 June 11, 2009 United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549-4561 Attn: Mr. Stephen Krikorian Re: CompuMed, Inc. Form 10-KSB/A for the Fiscal Year Ended September 30, 2008 |
|
| May 26, 2009 |
5777 W. Century Blvd., Suite 360 Los Angeles, CA 90045 Tel: (310) 258-5000 Fax: (310) 645-5880 May 26, 2009 Delivered by electronic submission via EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549-4561 Attn: Mr. Stephen Krikorian Dear Mr. Stephen Krikorian: We received your letter dated May 14, 2009 and we note your reque |
|
| May 15, 2009 |
United States Securites and Exchange Commission Edgar Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 5, 2009 |
United States Securities & Exchange Commission EDGAR Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 5, 2009 |
Issue No. 5 ***Special Investor Q & A #2*** April 2009 Exhibit 99.1 Issue No. 5 ***Special Investor Q & A #2*** April 2009 Quick Links Stock Quote Telecardiology Services Skeletal Health Press Room Investor Relations Greetings! Welcome to the second in our special three part series of CompuMEDLINE newsletters focused on answering specific investor questions. The first newsletter in this series was distributed a few weeks ago and focused on CompuMed's |
|
| April 30, 2009 |
[Frederic Dorwart, Lawyers Letterhead] April 30, 2009 [Frederic Dorwart, Lawyers Letterhead] April 30, 2009 Delivered by electronic submission via EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N. |
|
| April 15, 2009 |
Issue No. 4 ***Special Investor Q & A*** April 2009 EX-99.1 2 compu991.htm Exhibit 99.1 Issue No. 4 ***Special Investor Q & A*** April 2009 Quick Links Stock Quote Telecardiology Services Skeletal Health Press Room Investor Relations Greetings! I hope this newsletter finds you well and in good spirits despite the troubled economy. Even with the deepening recession, CompuMed continues to build demand for its products and services. We're riding out t |
|
| April 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2009 ——————— COMPUMED, INC. (Exact name of registrant as specified in its charter) ——————— DELAWARE 000-14210 95-2860434 (State or Other Jurisdiction (Commis |
|
| April 13, 2009 |
5777 W. Century Blvd., Suite 360 Los Angeles, CA 90045 Tel: (310) 258-5000 Fax: (310) 645-5880 April 13, 2009 Delivered by electronic submission via EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549-4561 Attn: Mr. Stephen Krikorian Re: CompuMed, Inc. Form 10-KSB/A for the Fiscal Year Ended September 30, 2008 Filed Decembe |
|
| February 17, 2009 |
Exhibit 10.2 January 7, 2009 Re: Financial advisor for CompuMed, Inc. Dear Mr. Crockett: This letter sets forth the terms and conditions on which CompuMed, Inc. (the "Company") has engaged Mark Crockett (the ?Advisor?) for a period of 8 months from the date of this letter (the ?Term?) to provide certain investment banking and financial advisory services in connection with a possible Transaction (a |
|
| February 17, 2009 |
United State Securities and Exchange Commission Edgar Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 30, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-KSB/A ——————— ü ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: SEPTEMBER 30, 2008 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ——————— COMPUMED, INC. (Exact name of |
|
| December 29, 2008 | ||
| December 18, 2008 |
AMENDED REVOLVING LINE OF CREDIT AGREEMENT EXHIBIT 10.26 AMENDED REVOLVING LINE OF CREDIT AGREEMENT This Amended Revolving Line of Credit Agreement (the "Agreement") is made and entered into in this 16th day of December, 2008 (the “Effective Date”), by and between Boston Avenue Capital, LLC, an Oklahoma limited liability company ("Lender"), and CompuMed, Inc., a Delaware corporation ("Borrower"). WHEREAS, Lender and Borrower entered into a |
|
| December 18, 2008 |
COMPUMED RESTRUCTURES $4 MILLION LINE OF CREDIT EXHIBIT 99.1 COMPUMED RESTRUCTURES $4 MILLION LINE OF CREDIT LOS ANGELES, Dec 17, 2008 - CompuMed, Inc. (CMPD.OB) (www.compumed.net) - a medical informatics company serving the healthcare community with diagnostic software solutions - today announced that the Company has entered into a new agreement with Boston Avenue Capital, LLC ("BAC") which restructures its $4 million line of credit to provide |
|
| December 18, 2008 |
United States Securities & Exchange Commission EDGAR Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2008 COMPUMED, INC. |
|
| October 17, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2008 ——————— COMPUMED, INC. (Exact name of registrant as specified in its charter) ——————— DELAWARE 000-14210 95-2860434 (State or Other Jurisdiction (Comm |
|
| October 17, 2008 |
CompuMedLINE Issue: 3 October 2008 EXHIBIT 99.1 CompuMedLINE Issue: 3 October 2008 Greetings! Welcome to our Fall edition of CompuMEDLine. This has been a tumultuous time in the financial markets and the business climate has generally been terrible. However, CompuMed begun a strategy to conserve cash at the beginning of the year, and that strategy should allow us to continue to reduce our cash burn with the goal of becoming profita |
|
| August 14, 2008 |
10Q Compumed UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2008 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to ——————— COMPUMED, INC. (Ex |
|
| July 29, 2008 |
Exhibit 99.1 CompuMed Receives Regulatory Clearance by China?s State Food and Drug Administration for OsteoGram Product Los Angeles ? July 28, 2008 - CompuMed, Inc. (CMPD.OB) - a medical informatics company serving the healthcare community with diagnostic software solutions - today announced it has received approval from the State Food and Drug Administration (SFDA) of the People?s Republic of Chi |
|
| July 29, 2008 |
United States Securities & Exchange Commission UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 12, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2008 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorpora |
|
| May 29, 2008 |
Exhibit 99.1 CompuMed, Inc. Teams with OSI Systems, Inc. to Provide Practical and Affordable Bone Density Screening Solutions at the Point-Of-Care In Connection With Agreement,CompuMed Launches NewOsteoCare? Clinical Network For Bone Mineral Density (BMD) Testing In Primary Care Settings Los Angeles - May 29, 2008 - CompuMed, Inc. (OTCBB:CMPD) - a medical technology company serving the healthcare |
|
| May 29, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2008 ——————— COMPUMED, INC. (Exact name of registrant as specified in its charter) ——————— DELAWARE 000-14210 95-2860434 (State or Other Jurisdiction (Commissi |
|
| May 23, 2008 |
CompuMed, Inc. Elects Mark Crockett to Board of Directors EXHIBIT 99.1 CompuMed, Inc. Elects Mark Crockett to Board of Directors Los Angeles ? May 22, 2008 ? CompuMed Inc. (OTCBB:CMPD) - a medical informatics company serving the healthcare community with diagnostic software solutions - today announced the election of Mark Crockett to its Board of Directors. The company also announced the election of Mark Stolper as Board chairman, replacing Simon James, |
|
| May 23, 2008 |
Compumed, Inc 8k UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2008 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or Other Jurisdiction (Commission (I.R.S. Empl |
|
| May 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) 10QSB Compumed UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) x QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE TRANSITION PERIOD FROM TO COMPUMED, INC. (Exact name of regi |
|
| May 15, 2008 |
OFFICE LEASE Exhibit 10.24 OFFICE LEASE by and between L. A. T. INVESTMENT CORPORATION, a California corporation “Landlord” and COMPUMED, INC. a Delaware corporation “Tenant” Effective Date March 1, 2008 TABLE OF CONTENTS Page 1. Parties 1 2. Summary of Basic Terms 1 3. Demise and Term 2 4. Possession and Commencement 2 5. Monthly Rent 2 6. Security Deposit 3 7. Operating Expenses 3 8. Use of Prem |
|
| May 8, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2008 ——————— COMPUMED, INC. (Exact name of registrant as specified in its charter) ——————— DELAWARE 000-14210 95-2860434 (State or Other Jurisdiction (Commissio |
|
| May 8, 2008 |
EXHIBIT 99.1 CompuMedLINE Issue: 2 May 2008 Greetings! In this second edition of the CompuMedLINE newsletter we focus on CompuMed's telecardiology business unit. We recently expanded our service platforms to add capabilities and improve quality-of-service. These enhancements should enable us to expand our telecardiology business from traditional correctional markets to many other exciting growth m |
|
| May 1, 2008 |
EXHIBIT 99.1 COMPUMED, INC. ANNOUNCES STATEWIDE CONTRACT TO PROVIDE REMOTE ECG SCREENING Wexford Health Sources Has Selected CompuMed?s CardioGram ECG Terminals and Service For West Virginia Division of Corrections Contract LOS ANGELES, April. 28, 2008 - CompuMed, Inc. (CMPD.OB) - a medical informatics company serving the healthcare community with diagnostic software solutions - today announced th |
|
| May 1, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 8-K ——————— CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2008 ——————— COMPUMED, INC. (Exact name of registrant as specified in its charter) ——————— DELAWARE 000-14210 95-2860434 (State or Other Jurisdiction (Commis |
|
| March 20, 2008 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 20, 2008 |
Exhibit 99.1 Nevada Department Of Corrections Extends Contract With CompuMed, Inc. To Provide Remote ECG Screening Department of Corrections Signs Two-Year Extension To Use CardioGram ECG Terminals and Services Los Angeles - March 17, 2008 - CompuMed, Inc. (CMPD.OB) - a medical informatics company serving the healthcare community with diagnostic software solutions - today announced that it has bee |
|
| February 27, 2008 |
sc13dza OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. |
|
| February 19, 2008 |
EXHIBIT 99.1 CompuMed Secures a $4 Million Line of Credit for Growth Initiatives and Future Expansion Simon James appointed Chairman of the Board and Veteran Investor Charles Gillman Joins the Board of Directors Los Angeles ? February 19, 2008 - CompuMed, Inc. (CMPD.OB) ? a medical informatics company serving the healthcare community with diagnostic software solutions - today announced that the Co |
|
| February 19, 2008 |
REVOLVING LINE OF CREDIT AGREEMENT Exhibit 10.19 EXHIBIT 10.19 REVOLVING LINE OF CREDIT AGREEMENT This Revolving Line of Credit Agreement (the "Agreement") is made and entered into in this 15th day of February, 2008, by and between Boston Avenue Capital, LLC, an Oklahoma limited liability company ("Lender"), and CompuMed, Inc., a Delaware corporation ("Borrower"). In consideration of the mutual covenants and agreements contained he |
|
| February 19, 2008 |
Exhibit 10.20 EXHIBIT 10.20 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN |
|
| February 19, 2008 |
CERTIFICATE OF AMENDMENT TO AMENDED RIGHTS AGREEMENT OF COMPUMED, INC. EXHIBIT 4.7 AMENDED RIGHTS AGREEMENT This Amended Rights Agreement(this "Agreement"),is dated as of February , 2008 between CompuMed, Inc., a Delaware corporation (the "COMPANY"), and Computershare (the "RIGHTS AGENT"). Capitalized terms included in this Agreement shall have the meaning set forth herein. W I T N E S S E T H: WHEREAS, on October 28, 2005, the Board of Directors of the Company (i) a |
|
| February 19, 2008 |
EXHIBIT 10.21 EXHIBIT 10.21 AGREEMENT THIS AGREEMENT (the “Agreement”) is entered into as of February 15, 2008 (the “Effective Date”), by and between CompuMed, Inc., a Delaware corporation (the “Company”); Boston Avenue Capital, LLC (“BAC”), an Oklahoma limited liability company; and Robert Stuckelman, John Romm, M.D., and Stuart Silverman, M.D., each a resident of California and John Minnick, a r |
|
| February 19, 2008 |
CERTIFICATE OF AMENDMENT TO BYLAWS OF COMPUMED, INC. Exhibit 3.7 EXHIBIT 3.7 CERTIFICATE OF AMENDMENT TO BYLAWS OF COMPUMED, INC. The undersigned certifies that: 1. The undersigned is the Chief Executive Officer and President of CompuMed, Inc. (the “Company”), a Delaware corporation. 2. Article III Section 2 of the Company’s Bylaws shall be amended to read as follows: “The board of directors shall consist of not less than three (3) nor more than sev |
|
| February 19, 2008 |
CompuMed 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of Earliest Event Reported): February 15, 2008 Commission file number: 000-14210 COMPUMED, INC. |
|
| February 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) 10QSB Compumed UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) x QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2007 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE TRANSITION PERIOD FROM TO COMPUMED, INC. (Exact name of r |
|
| January 25, 2008 |
8-K 1 f8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2007 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or other jurisdiction of incorporati |
|
| January 25, 2008 |
EX-99.1 2 ex991.htm EXHIBIT 99.1 EXHIBIT 99.1 COMPUMEDLINE NEWSLETTER Greetings! Welcome to the inaugural edition of the CompuMedLINE newsletter. Our goal is to keep customers and other CompuMed stakeholders up to speed on how our unique technology is helping streamline provider workflow, improve patient care and reduce costs. In each issue, we will cover new product developments, market trends an |
|
| December 28, 2007 |
As of September 30, 2007, we have no subsidiaries. EXHIBIT 21 EXHIBIT 21.1 As of September 30, 2007, we have no subsidiaries. |
|
| December 28, 2007 |
CompuMed 10KSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB [X] ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2007 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE TRANSITION PERIOD FROM TO COMPUMED, INC. (Exact name of registrant as |
|
| December 10, 2007 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2007 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or other jurisdiction of incorporation) (Com |
|
| December 10, 2007 |
CompuMed to Publish E-Newsletter for Customers and Investors Exhibit 99.1 CompuMed to Publish E-Newsletter for Customers and Investors Los Angeles ? December 10, 2007 ? CompuMed, Inc. (CMPD.OB) - a medical informatics company serving the healthcare community with diagnostic software solutions ? today announced that it will launch ?CompuMedLINE? - an electronic newsletter designed to provide customers, investors and other CompuMed?s stakeholders with compreh |
|
| November 26, 2007 |
Exhibit 99.1 COMPUMED INTRODUCES NEW FEATURES FOR OSTEOGRAM BONE DENSITY SCREENING SOFTWARE TO IMPROVE SPEED AND WORKFLOW OsteoGram On Display at RSNA Annual Meeting with OEM Partners CareStream Health, Fuji, Swissray, AMS and IDC Los Angeles and Chicago (RSNA Annual Meeting) – November 26, 2007 - CompuMed, Inc. (CMPD.OB) – a medical informatics company serving the healthcare community with diagno |
|
| November 26, 2007 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 26, 2007 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or other jurisdiction of incorporation) (Com |
|
| October 15, 2007 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2007 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or other jurisdiction of incorporation) (Comm |
|
| October 15, 2007 |
Exhibit 99.1 COMPUMED, INC. AWARDED US PATENT FOR TECHNOLOGY TO MONITOR JOINT DISEASE Patent Covers Automated Method and System with Applications for Osteoarthritis and Rheumatoid Arthritis LOS ANGELES - October 15, 2007 - CompuMed, Inc. (CMPD.OB) ? a leading provider of imaging technology for skeletal health, and the company behind the OsteoGram? system for bone density screening, today announced |
|
| October 9, 2007 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2007 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or other jurisdiction of incorporation) (Commission |
|
| October 9, 2007 |
COMPUMED, INC. ANNOUNCES NEW CALIFORNIA STATEWIDE CONTRACT FOR ECG SERVICES Exhibit 99.1 Exhibit 99.1 COMPUMED, INC. ANNOUNCES NEW CALIFORNIA STATEWIDE CONTRACT FOR ECG SERVICES Company Wins California Department of Corrections Contract; Expands Network of Sites Using its ECG Services LOS ANGELES - October 8, 2007 - CompuMed, Inc. (CMPD.OB) – which operates one of the largest networks of tele-cardiology systems for remote analytics - today announced that it has been award |
|
| September 4, 2007 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2007 COMPUMED, INC. (Exact name of registrant as specified in its charter) DELAWARE 000-14210 95-2860434 (State or other jurisdiction of incorporation) (Commission |
|
| September 4, 2007 |
Welcome Welcome Special Shareholders Meeting 1 This presentation includes forward-looking statements that are based on certain assumptions and reflect our current expectations. |
